Úlcera esofágica por comprimido de L-Arginina: causa no comunicada previamente de esofagitis por comprimidos

Blanca Gallego Pérez, Juan José Martínez Crespo, Daniel García Belmonte, Carmen María Marín Bernabé

Resumen


-

Palabras clave


-

Texto completo:

PDF

Referencias


Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf. 2000 Mar;22(3):237-49.

Abid S, Mumtaz K, Jafri W, Hamid S, Abbas Z, Shah HA, Khan AH. Pill-induced esophageal injury: endoscopic features and clinical outcomes. Endoscopy. 2005 Aug;37(8):740-4.

Smith SJ, Lee AJ, Maddix DS, Chow. Pill-induced esophagitis caused by oral rifampicin. A W Ann Pharmacother. 1999 Jan; 33(1): 27-31.

Forbes SC, Harber V, Bell GJ. Oral L-Arginine Prior To Resistance Exercise Blunts Growth Hormone in Strength Trained Males. Int J Sport Nutr Exerc Metab. 2013 Nov 13.

Nagahama K, Nishio H, Yamato M, Takeuchi K. Orally administered L-arginine and glycine are highly effective against acid reflux esophagitis in rats. Med Sci Monit. 2012 Jan;18(1):BR9-15.

Forbes SC, Harber V, Bell GJ. The acute effects of L-arginine on hormonal and metabolic responses during submaximal exercise in trained cyclists. Int J Sport Nutr Exerc Metab. 2013 Aug;23(4):369-77.

Pinos T, Figueras C, Mas R, Doxicycline-induced esophagitis: treatment with liquid sucralphate. Am. J Gastroenterol 1990; 85:902-3

Yamaoka K, Takenawa H, Tajiri K, Yamane M, Kadowaki K, Marumo F, Sato C, A case of esophageal perforation due to a pill-induced ulcer successfully treated with conservative measures. Am J Gastroenterol. 1996 May;91(5):1044-5.




DOI: http://dx.doi.org/10.7399%2Ffh.2014.38.6.7356

Enlaces refback

  • No hay ningún enlace refback.


Incluida en:

Bibliovigilance Dialnet DOAJ Dulcinea EBSCO Embase ESCI Ibecs Latindex MEDES mEDRA MIAR PUBMED REDALYC Redib SciELO SCOPUS Sherpa/Romero

Farmacia Hospitalaria

Sociedad Española de Farmacia Hospitalaria. C/ Serrano n. 40 2º Dcha. - 28001 Madrid

eISSN: 2171-8695 

ISSN-L: 1130-6343

Dep. Legal: M-39835-2012

Correo electrónico de contacto: [email protected]

Los artículos publicados en esta revista se distribuyen con la licencia: Creative Commons Attribution 4.0.

La revista Farmacia Hospitalaria no cobra tasas por el envío de trabajos, ni tampoco cuotas por la publicación de sus artículos.